The Enterprise Value as of December 2025 (TTM) for Frontage Holdings Corporation (1521.HK) is 367.21M

According to Frontage Holdings Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 367.21M. This represents a change of -24.50% compared to the average of 486.38M of the last 4 quarters.

Frontage Holdings Corporation (1521.HK) Historical Enterprise Value (quarterly & annually)

How has 1521.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Frontage Holdings Corporation over the last ten years is 818.46M. The current 367.21M Enterprise Value has changed 4.39% with respect to the historical average. Over the past ten years (40 quarters), 1521.HK's Enterprise Value was at its highest in in the June 2021 quarter at 2.10B. The Enterprise Value was at its lowest in in the January 2016 quarter at 0.

Frontage Holdings Corporation (1521.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Frontage Holdings Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Frontage Holdings Corporation (1521.HK) Average Enterprise Value

How has 1521.HK Enterprise Value performed in the past?

The current Enterprise Value of Frontage Holdings Corporation (1521.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Frontage Holdings Corporation (1521.HK) Enterprise Value vs. Peers

How is 1521.HK’s Enterprise Value compared to its peers?

Frontage Holdings Corporation’s Enterprise Value is less than Cutia Therapeutics (1.79B), less than HighTide Therapeutics Inc (1.30B), less than SinoMab BioScience Limited (1.91B), less than Mabpharm Limited (2.38B), less than Shanghai Bio-heart Biological Technology Co., Ltd. (1.09B), less than Clover Biopharmaceuticals, Ltd. (2.63B), less than Shanghai Pioneer Holding Ltd (2.27B), less than JBM (Healthcare) Limited (2.35B), less than Immunotech Biopharm Ltd (1.45B), less than Essex Bio-Technology Limited (1.82B),

Build a custom stock screener for Frontage Holdings Corporation (1521.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Frontage Holdings Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Frontage Holdings Corporation (1521.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Frontage Holdings Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.